大熊制药
A mostrar 17–32 de 65 resultados
-
TENODX Tenofovir Alafenamide
Tenofovir alafenamide (TAF) is a nucleotide reverse transcriptase inhibitor and a prodr…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
TAZEDX Tazemetostat
TAZEMETOSTAT is a drug that targets a protein in cancer cells and stops them from growi…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
REPODX Repotrectinib
Repotrectinib is a next-generation tyrosine kinase inhibitor that targets the ROS1 and …Escolher opcao This product has multiple variants. The options may be chosen on the product page -
TOFADX Tofacitinib
Tofacitinib is a JAK inhibitor that effectively inhibits the activity of JAK1 and JAK3,…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
BESIDX Abemaciclib
Abemaciclib is a selective CDK4 and CDK6 inhibitor used to treat advanced or metastatic…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
KESODX Crizotinib
Crizotinib is an ALK and ROS1 inhibitor used to treat non-small cell lung cancer. Crizo…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
Mobocertinib Capsules (MOBODX) 40mg – Buy Online
The U.S. FDA has granted accelerated approval to mobotinib for the treatment of adult p…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
BARUDX Baricitinib
Baricitinib is a selective, reversible JAK1 and JAK2 inhibitor that is taken orally onc…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
AIVODX Ivosidenib 250mg
Ivosidenib is the world's first approved IDH1 inhibitor. In July 2018, Ivosidenib was a…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
ENTREDX Entrectinib 200mg
Entrectinib is an inhibitor of tropomyosin receptor tyrosine kinase (TRK) TRKA, TRKB, T…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
WELIDX Belzutifan
Belzutifan is a HIF-2α inhibitor. HIF, or hypoxia-inducible factor, is a key oncogenic …Escolher opcao This product has multiple variants. The options may be chosen on the product page -
TUKADX Tucatinib 150mg
Tucatinib is a small-molecule oral tyrosine kinase inhibitor (TKI) that was approved fo…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
RUSODX Ruxolitinib 5mg
In November 2011, ruxolitinib tablets were first approved for marketing in the United S…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
ERDADX Erdafitinib 4mg
In March 2018, the U.S. Food and Drug Administration (FDA) granted erdatinib Breakthrou…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
SEPADX Selpercatinib 40mg
On May 8, 2020, the U.S. Food and Drug Administration (FDA) approved selpercatinib, the…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
LENVIDX Lenvatinib 10mg
Lenvatinib is a multi-target receptor tyrosine kinase (RTK) inhibitor that inhibits vas…Escolher opcao This product has multiple variants. The options may be chosen on the product page
